B cells in multiple sclerosis

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 786-796

  Burgoon, Mark P ^a   Gilden, Donald H ^a   Owens, Gregory P ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Antibodies; B cells; Central Nervious System; CNS; MS; Multiple Sclerosis; Neurologic Disease; Oligoclonal Bands; Review

Indexed keywords

AUTOANTIGEN; IMMUNOGLOBULIN G; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; AUTOANTIBODY;

AUTOIMMUNITY; B LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CHLAMYDIA; HERPES VIRUS; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELINATION; NONHUMAN; OLIGODENDROGLIA; RETROVIRUS; REVIEW; TARGET CELL; ANIMAL; IMMUNOLOGY; PATHOLOGY;

CHLAMYDIA; HERPESVIRIDAE; UNIDENTIFIED RETROVIRUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; MULTIPLE SCLEROSIS;

EID: 2542466801     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1278     Document Type: Review

References (123)

1. Kurtzke J. F. & Q. H. Bui: Multiple sclerosis in a migrant population: 2. Half-orientals immigrating in childhood. Ann Neurol 8, 256-260 (1980)
2. Kurtzke J. F., N. Delasnerie-Laupretre & M. T. Wallin: Multiple sclerosis in North African migrants to France. Acta Neurol Scand 98, 302-309 (1998)
3. Spielman R. S. & N. Nathanson: The genetics of susceptibility to multiple sclerosis. Epidemiol Rev 4, 45-65 (1982)
4. Vandvik B., E. Norrby, H. J. Nordal & M. Derge: Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol 5, 979-992 (1976)
5. Vandvik B., E. Norrby, J. Steen-Johnsen & K. Stensvold: Mumps meningitis: prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid. Eur Neurol 17, 13-22 (1978)
6. Porter K. G., D. G. Sinnamon & R. R. Gillies: Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in Cryptococcal meningitis. Lancet 1, 1262 (1977)
7. Grimaldi, L. M. E., R. P. Roos, S. G. Devare, J. M. Casey, Y. Maruo, T. Hamada & K. Tashiro: HTLV-1-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-1 p24 antibody. Ann Neurol 24, 727-731 (1988)
8. Burgoon M. P., B. N. Hammack, G. P. Owens, A. L. Mayback, M. J. Eikelenboom & D. H. Gilden: Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Ann Neurol 54, 459-463 (2003)
9. Gilden D. H., M. E. Devlin, M. P. Burgoon & G. P. Owens: The search for virus in multiple sclerosis brain. Multiple Sclerosis 2, 179-183 (1996)
10. Glynn P., D. Weedon, J. Edwards, A. J. Suckling & M. L. Cuzner: Humoral immunity in chronic relapsing experimental autoimmune encephalomyelitis: the major oligoclonal IgG bands are antibodies to mycobacteria. J Neurol Sci 57, 369-384 (1982)
11. Padgett B. L., D. L. Walker, G. M. ZuRhen, R. J. Eckroade & B. H. Dessel: Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1, 1257-1260 (1971)
12. Lumsden C. E.: The immunogenesis of the multiple sclerosis plaque. Brain Res 28, 365-390 (1971)
13. Lassmann H., C. S. Raine, J. Antel & J. W. Prineas: Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86, 213-217 (1998)
14. Esiri M. M.: Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet 2, 478-480 (1977)
15. Prineas J. W.: The neuropathology of multiple sclerosis. In: Handbook of Clinical Neurology. Eds: Vinken P. J., G. W. Bruyn, H. L. Klawans & J. C. Koetsier, Elsevier Science Publishers, Amsterdam-New York, Vol. 3, 213-257 (1985)
16. Archelos J. J., M. K. Storch & H. P. Hartung: The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 47, 694-706 (2000)
17. Prineas J. W. & J. S. Graham: Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 10, 149-158 (1981)
18. Prineas J. W., E. E. Kwon, P. Z. Goldenberg, A. A. Ilyas, R. H. Quarles, J. A. Benjamins & T. J. Sprinkle: Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61, 489-503 (1989)
19. Prineas J. W., E. E. Kwon, P. Z. Goldenberg, E. -S. Cho & L. R. Sharer: Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab Invest 63, 624-636 (1990)
20. Woyciechowska J. L. & W. J. Brzosko: Immunofluorescence study of brain plaques from two patients with multiple sclerosis. Neurology 27, 620-622 (1977)
21. Gay D. & M. Esiri: Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study. Brain 114, 557-572 (1991)
22. Gay F. W., T. J. Drye, G. W. Dick & M. M. Esiri: The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesions. Brain 120, 1461-1483 (1997)
23. Storch M. K., S. Piddlesden, M. Haltia, M. Iivanainen, P. Morgan & H. Lassmann: Multiple Sclerosis: in situ evidence for Ab- and complement-mediated demyelination. Ann Neurol 43, 465-471 (1998)
24. Lucchinetti C., W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez & H. Lassmann: Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47, 707-717 (2000)
25. Scolding N. J., B. P. Morgan, W. A. Houston, C. Linington, A. K. Campbell & D. A. Compston: Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 339, 620-622 (1989)
26. Bernard C. C. & P. R. Carnegie: Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J Immunol 115, 1537-1540 (1975)
27. Owens T. & S. Sriram: The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol Clin 13, 51-73 (1995)
28. Linington C., B. Engelhardt, G. Kapocs & H. Lassman: Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 40, 219-224 (1992)
29. Genain C. P., M. H. Nguyen, N. L. Letvin, R. Pearl, R. L. Davis, M. Adelman, M. B. Lees, C. Linington & S. L. Hauser: Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 96, 2966-2974 (1995)
30. Jones R. E., Y. Chou, A. Young, M. Mass, A. Vandenbark, H. Offner & D. Bourdette: T cells with encephalitogenic potential from multiple sclerosis patients and Lewis rats fail to induce disease in SCID mice following intracisternal injection. J Neuroimmunol 56, 119-126 (1995)
31. Lavi E. & A. Rostami: Demyelination following transfer of human lymphocytes into mice with severe combined immunodeficiency. Pathobiology 64, 136-141 (1996)
32. Saeki Y., T. Mima, S. Sakoda, H. Fujimura, N. Arita, T. Nomura & T. Kishimoto: Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc Natl Acad Sci USA 89, 6157-6161 (1992)
33. Prineas J. W., E. E. Kwon, E. -S. Cho, L. R. Sharer, M. H. Barnett, E. L. Oleszak, B. Hoffman & B. P. Morgan: Immunopathology of secondary- progressive multiple sclerosis. Ann Neurol 50, 646-657 (2001)
34. Paty D. W., D. K. Li, UBC MS/MRI Study Group & IFNB Multiple Sclerosis Study Group: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 662-667 (1993)
35. Jacobs L. D., R. W. Beck, J. H. Simon, P. Kinkel, C. M. Brownscheidle, T. J. Murray, N. A. Simonian, P. J. Slasor, A. W. Sandrock & the CHAMPS Study Group: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343, 898-904 (2000)
36. Noseworthy J. H., C. Lucchinetti, M. Rodriguez & B. G. Weinshenker: Multiple sclerosis. N Engl J Med 343, 938-952 (2000)
37. Weinstock-Guttman B., R. M. Ransohoff, R. P. Kinkel & R. A. Rudick: The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 37, 7-15 (1995)
38. Lycke J., B. Svennerholm, E. Hjelmquist, L. Frisén, G. Badr, M. Andersson, A. Vahlne & O. Andersen: Acyclovir treatment of relapsing-remitting multiple sclerosis: a randomized, placebo-controlled, double-blind study. J Neurol 243, 214-224 (1996)
39. Steiner I. & I. Wirguin: Multiple sclerosis - in need of a critical reappraisal. Med Hypotheses 54, 99-106 (2000)
40. Poser C. M., D. W. Paty, L. Scheinberg, W. I. McDonald, F. A. Davis, G. C. Ebers, K. P. Johnson, W. A. Sibley, D. H. Silberberg & W. W. Tourtellotte: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13, 227-231 (1983)
41. Poser C. M. & V. V. Brinar: Problems with diagnostic criteria for multiple sclerosis. Lancet 358, 1746-1747 (2001)
42. Cross A. H., J. L. Trotter & J. -A. Lyons: B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112, 1-14 (2001)
43. Correale J. & M. de los Milagros Bassani Molinas: Oligoclonal bands and antibody responses in multiple sclerosis. J Neurol 249, 375-389 (2002)
44. Traugott U., S. Snyder & C. S. Raine: Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Ann Neurol 6, 13-20 (1979)
45. Edgington T. S. & D. J. Dalessio: The assessment by immunofluorescence methods of humoral anti-myelin antibodies in man. J Immunol 105, 248-255 (1970)
46. Steck A. J. & H. Link: Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studies. Acta Neurol Scand 70, 81-89 (1984)
47. Sedzik J., A. E. Blaurock & M. Hochli: Lipid/myelin basic protein multilayers. A model for the cytoplasmic space in central nervous system myelin. J Mol Biol 174, 385-409 (1984)
48. Brunner C., H. Lassmann, T. V. Waehneldt, J. M. Matthieu & C. Linington: Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J Neurochem 52, 296-304 (1989)
49. Warren K. G. & I. Catz: Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J Neurol Sci 121, 66-73 (1994)
50. Warren K. G., I. Catz, E. Johnson & B. Mielke: Antimyelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann Neurol 35, 280-289 (1994)
51. Soderstrom M., H. Link, Z. Xu & S. Fredriksson: Optic neuritis and multiple sclerosis: anti-MBP and anti-MBP peptide antibody-secreting cells are accumulated in CSF. Neurology 43, 1215-1222 (1993)
52. Olsson T., S. Baig, B. Hojeberg & H. Link: Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann Neurol 27, 132-136 (1990)
53. Reindl M., C. Linington, U. Brehm, R. Egg, E. Dilitz, F. Deisenhammer, W. Poewe & T. Berger: Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122, 2047-2056 (1999)
54. Cruz M., T. Olsson, J. Ernerudh, B. Hojeberg & H. Link: Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis. Neurology 37, 1515-1519 (1987)
55. O'Connor K. C., T. Chitnis, D. E. Griffin, S. Piyasirisilp, A. Bar-Or, S. Khoury, K. W. Wucherpfennig & D. A. Hafler: Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol 136, 140-148 (2003)
56. Chou C. H., W. W. Tourtellotte & R. F. Kibler: Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS. Neurology 33, 24-28 (1983)
57. Brokstad K. A., M. Page, H. Nyland & L. R. Haaheim: Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients. Acta Neurol Scand 89, 407-411 (1994)
58. Lebar R., C. Lubetzki, C. Vincent, P. Lombrail & J. M. Boutry: The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin Exp Immunol 66, 423-434 (1986)
59. Linington C. & H. Lassmann: Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol, 17, 61-69 (1987)
60. Xiao B. G., C. Linington & H. Link: Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31, 91-96 (1991)
61. Genain C. P., B. Cannella, S. L. Hauser & C. S. Raine: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5, 170-175 (1999)
62. Sun J., H. Link, T. Olsson, B. G. Xiao, G. Andersson, H. P. Ekre, C. Linington & P. Diener: T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 146, 1490-1495 (1991)
63. Karni A., R. Bakimer-Kleiner, O. Abramsky & A. Ben Nun: Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch Neurol 56, 311-315 (1999)
64. Haase C. G., J. Guggenmos, U. Brehm, M. Andersson, T. Olsson, M. Reindl, J. M. Schneidewind, U. K. Zettl, F. Heidenreich, T. Berger, H. Wekerle, R. Hohlfeld & C. Linington: The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol 114, 220-225 (2001)
65. Berger T., P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer & M. Reindl: Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349, 139-145 (2003)
66. Walsh M. J. & J. M. Murray: Dual implication of 2′,3′- cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J Clin Invest 101, 1923-1931 (1998)
67. Link H. & R. Muller: Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol 25, 326-344 (1971)
68. Link H. & M. A. Laurenzi: Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation. Ann Neurol 6, 107-110 (1979)
69. Moller J. R., D. Johnson, R. O. Brady, W. W. Tourtellotte & R. H. Quarles: Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 22, 55-61 (1989)
70. Andersson M., M. Yu, M. Soderstrom, S. Weerth, S. Baig, G. Solders & H. Link: Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis. Eur J Neurol 9, 243-251 (2002)
71. Bronstein J. M., R. L. Lallone, R. S. Seitz, G. W. Ellison & L. W. Myers: A humoral response to oligodendrocyte-specific protein in MS: a potential molecular mimic. Neurology 53, 154-161 (1999)
72. Agius M. A., C. A. Kirvan, A. L. Schafer, E. Gudipati & S. Zhu: High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease. Acta Neurol Scand 100, 139-147 (1999)
73. Birnbaum G. & L. Kotilinek: Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann N Y Acad Sci 835, 157-167 (1997)
74. Banki K., E. Colombo, F. Sia, D. Halladay, D. H. Mattson, A. H. Tatum, P. T. Massa, P. E. Phillips & A. Perl: Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med 180, 1649-1663 (1994)
75. Colombo E., K. Banki, A. H. Tatum, J. Daucher, P. Ferrante, R. S. Murray, P. E. Phillips & A. Perl: Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest 99, 1238-1250 (1997)
76. Mayo I., J. Arribas, P. Villoslada, D. R. Alvarez, S. Rodriguez-Vilarino, X. Montalban, M. R. De Sagarra & J. G. Castano: The proteasome is a major autoantigen in multiple sclerosis. Brain 125, 2658-2667 (2002)
77. Williamson R. A., M. P. Burgoon, G. P. Owens, O. Ghausi, E. Leclerc, L. Firme, S. Carlson, J. Corboy, P. W. Parren, P. P. Sanna, D. H. Gilden & D. R. Burton: Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci USA 98, 1793-1798 (2001)
78. Celet B., G. Akman-Demir, P. Serdaroglu, S. P. Yentur, B. Tasci, J. M. van Noort, M. Eraksoy & G. Saruhan-Direskeneli: Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 247, 935-939 (2000)
79. Gao Y. L., C. S. Raine & C. F. Brosnan: Humoral response to hsp 65 in multiple sclerosis and other neurologic conditions. Neurology 44, 941-946 (1994)
80. nd edition. Lippincott-Raven, Philadelphia, PA (1998)
81. Norrby E.: Viral antibodies in multiple sclerosis. Prog Med Virol 24, 1-39 (1978)
82. Salmi A., M. Reunanen, J. Ilonen & M. Panelius: Intrathecal antibody synthesis to virus antigens in multiple sclerosis. Clin Exp Immunol 52, 241-249 (1983)
83. Forghani B., N. E. Cremer, K. P. Johnson, G. Fein & W. H. Likosky: Comprehensive viral immunology of multiple sclerosis. III. Analysis of CSF antibodies by radioimmunoassay. Arch Neurol 37, 616-619 (1980)
84. Cremer N. E., K. P. Johnson, G. Fein & W. H. Likosky: Comprehensive viral immunology of multiple sclerosis. II. Analysis of serum and CSF antibodies by standard serologic methods. Arch Neurol 37, 610-615 (1980)
85. Rostrom B., H. Link, M. A. Laurenzi, S. Kam-Hansen, E. Norrby & B. Wahren: Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis. Ann Neurol 9, 569-574 (1981)
86. Vartdal F., B. Vandvik & E. Norrby: Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 8, 248-255 (1980)
87. Salmi A. A., E. Norrby & M. Panelius: Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis. Infect Immun 6, 248-254 (1972)
88. Challoner P. B., K. T. Smith, J. D. Parker, D. L. MacLeod, S. N. Coulter, T. M. Rose, E. R. Schultz, J. L. Bennett, R. L. Garber, M. Chang, P. A. Schad, P. M. Stewart, R. C. Nowinski, J. P. Brown & G. C. Burmer. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 92, 7440-7444 (1995)
89. Soldan S. S., R. Berti, N. Salem, P. Secchiero, L. Flamand, P. A. Calabresi, M. B. Brennan, H. W. Maloni, H. F. McFarland, H. C. Lin, M. Patnaik & S. Jacobson: Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3, 1394-1397 (1997)
90. Akhyani N., R. Berti, M. B. Brennan, S. S. Soldan, J. M. Eaton, H. F. McFarland & S. Jacobson: Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 182, 1321-1325 (2000)
91. Sumaya C. V., L. W. Myers, G. W. Ellison & Y. Ench: Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17, 371-377 (1985)
92. Levin L. I., K. L. Munger, M. V. Rubertone, C. A. Peck, E. T. Lennette, D. Spiegelman & A. Ascherio: Multiple sclerosis and Epstein-Barr virus. JAMA 289, 1533-1536 (2003)
93. Cuomo L., P. Trivedi, M. R. Cardillo, F. M. Gagliardi, A. Vecchione, R. Caruso, A. Calogero, L. Frati, A. Gaggioni & G. Ragona: Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 63, 45-51 (2001)
94. Enbom M., F. Z. Wang, S. Fredrikson, C. Martin, H. Dahl & A. Linde: Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 6, 545-549 (1999)
95. Mirandola P., A. Stefan, E. Brambilla, G. Campadelli-Fiume & L. M. Grimaldi: Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 53, 1367-1368 (1999)
96. Taus C., E. Pucci, E. Cartechini, A. Fie, G. Giuliani, M. Clementi & S. Menzo: Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand 101, 224-228 (2000)
97. Hilton D. A., S. Love, A. Fletcher & J. H. Pringle: Absence of Epstein-Barr virus in multiple sclerosis as assessed by in situ hybridisation. J Neurol Neurosurg Psychiatry 57, 975-976 (1994)
98. Kolson D. L. & F. Gonzalez-Scarano: Endogenous retroviruses and multiple sclerosis. Ann Neurol 50, 429-430 (2001)
99. Clausen J.: Endogenous retroviruses and MS: using ERVs as disease markers. Int MS J 10, 22-28 (2003)
100. Perron H., C. Geny, A. Laurent, C. Mouriquand, J. Pellat, J. Perret & J. M. Seigneurin: Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 140, 551-561 (1989)
101. Christensen T., P. D. Sorensen, H. J. Hansen & A. Moller-Larsen: Antibodies against a human endogenous retrovirus and the preponderance of env splice variants in multiple sclerosis patients. Multiple Sclerosis 9, 6-15 (2003)
102. Dolei A., C. Serra, G. Mameli, M. Pugliatti, G. Sechi, M. C. Cirotto, G. Rosati & S. Sotgiu: Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58, 471-473 (2002)
103. Gaudin P., S. Ijaz, P. W. Tuke, F. Marcel, A. Paraz, J. M. Seigneurin, B. Mandrand, H. Perron & J. A. Garson: Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis. Rheumatology 39, 950-954 (2000)
104. Sriram S., C. W. Stratton, S. Yao, A. Tharp, L. Ding, J. D. Bannan & W. M. Mitchell: Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46, 6-14 (1999)
105. Tsai J. C. & D. H. Gilden: Chlamydia pneumoniae and multiple sclerosis: no significant association. Trends Microbiol 9, 152-154 (2001)
106. Choo Q. -L., G. Kuo, A. Weiner, L. Overby, D. Bradley & M. Houghton: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362 (1989)
107. Fearon D. T. & R. M. Locksley: The instructive role of innate immunity in the acquired immune response. Science 272, 50-53 (1996)
108. Mattson D. H., R. P. Roos & B. G. Arnason: Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature 287, 335-336 (1980)
109. Mattson D. H., R. P. Roos & B. G. Arnason: Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis brains. J Neuroimmunol 2, 261-276 (1982)
110. Sindic C. J. M., Ph. Monteyne & E. C. Laterre: The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Immunol 54, 75-80 (1994)
111. H4 germline segments in an acute multiple sclerosis brain. Ann Neurol 43, 236-243 (1998)
112. Baranzini, S. E., M. C. Jeong, C. Butunoi, R. S. Murray, C. C. Bernard & J. R. Oksenberg: B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163, 5133-5144 (1999)
113. Smith-Jensen T., M. P. Burgoon, J. Anthony, H. Kraus, D. H. Gilden & G. P. Owens: Comparison of IgG heavy chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology 54, 1227-1232 (2000)
114. Owens G. P., M. P. Burgoon, J. Anthony, B. K. Kleinschmidt-DeMasters & D. H. Gilden: The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes. Clin Immunol 98, 258-263 (2001)
115. Burgoon M. P., R. A. Williamson, G. P. Owens, O. Ghausi, R. B. Bastidas, D. R. Burton & D. H. Gilden: Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain. J Neuroimmunol 94, 204-211 (1999)
116. Burgoon M. P., G. P. Owens, T. Smith-Jensen, D. Walker & D. H. Gilden: Cloning the antibody response in humans with inflammatory CNS disease: Analysis of the expressed IgG repertoire in subacute sclerosing panencephalitis brain reveals disease-relevant antibodies that recognize specific measles virus antigens. J Immunol 163, 3496-3502 (1999)
117. Qin Y., P. Duquette, Y. Zhang, P. Talbot, R. Poole & J. Antel: Clonal expansion and somatic hypermutation of VH genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 102, 1045-1050 (1998)
118. Qin Y., P. Duquette, Y. Zhang, M. Olek, R. -R. Da, J. Richardson, J. P. Antel, P. Talbot, N. R. Cashman, W. W. Tourtellotte, H. Wekerle & S. van den Noort: Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest 83, 1081-1088 (2003)
119. Colombo M., M. Dono, P. Gazzola, S. Roncella, A. Valette, N. Chiorazzi, G. Mancardi & M. Ferrarini: Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164, 2782-2789 (2000)
120. Owens G. P., A. M. Ritchie, M. P. Burgoon, R. A. Williamson, J. R. Corboy & D. H. Gilden: Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 171, 2725-2733 (2003)
121. Brezinschek H. P., R. I. Brezinschek & P. E. Lipsky: Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 155, 190-202 (1995)
122. Kuppers R., M. Zhao, M. L. Hansmann & K. Rajewsky: Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 12, 4955-4967 (1993)
123. Maruyama M, K. -P. Lam & K. Rajewsky: Memory B-cell persistence is independent of persisting immunizing antigen. Nature 407, 636-642 (2000)